Lacosamide Tablets recall
FDA recall D-0626-2026 · initiated Jun 4, 2026
Annora Pharma Private Limited recalled Lacosamide Tablets in Jun 2026 — an FDA Class II recall (D-0626-2026) because Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 31,392 60-count bottles
Details
- Product
- Lacosamide Tablets, USP, C V, 100mg, Rx only, 60-count bottle, By: Annora Pharma Pvt., Ltd, Sangareddy -502313, Telangana, India, Manufactured for: Camber Pharmaceuticals, Inc., Piscataway, NJ 08854, NDC 31722-813-60.
- Recalling company
- Annora Pharma Private Limited
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Jun 4, 2026
- FDA report date
- Jul 1, 2026
Frequently asked
- Was Lacosamide Tablets recalled?
- Annora Pharma Private Limited recalled Lacosamide Tablets in Jun 2026 — an FDA Class II recall (D-0626-2026) because Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was Lacosamide Tablets recalled?
- Per the FDA enforcement record, the reason for recall D-0626-2026 was: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.
- Is a recalled Lacosamide Tablets dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of Lacosamide Tablets are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot: A253999, A254000, Expires: 09/30/2027.. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0626-2026.